when the body's own defence reaction goes into overdrive and attacks its own organs," explains Professor Dr. Sascha David from the Clinic for Kidney and Hypertension Diseases at the MHH and the Institute [...] supported with dialysis. "It is important to diagnose sepsis early and start therapy immediately," says Professor David. Without medical care, the risk of death increases by seven per cent per hour. Healthy plasma [...] exchange is not a new procedure. However, it is not yet established in the treatment of septic shock. Professor David's "Translational Intensive Care Medicine" working group, which also includes private lecturer

pies in order to better adapt the treatment to the individual needs of the patients," explains Professor Dr. Kai Kahl, head of the MHH study centre. The ChangePDD project is funded by the German Research [...] suffering cardiovascular diseases, slipping into incapacity to work and early retirement," says Professor Kahl. This is not only an extremely difficult situation for those affected personally, but also [...] Philippa Gebhardt is coordinating the study, six other study centres are involved in the project. Professor Dr Eva-Lotta Brakemeier from the University of Greifswald is in charge of the study. Established

inflammatory diseases, allergies, obesity and diabetes in the long term. A team led by scientist Professor Dr Dorothee Viemann, Hannover Medical School (MHH) and Cluster of Excellence RESIST as well as [...] Research (BMBF) is supporting this project with around 1.9 million euros. Alarmins could be the key Professor Viemann and PD Dr. Sabine Pirr had previously discovered that so-called alarmins positively influence [...] "The risk of sepsis increases significantly if premature babies lack alarmin S100A8/A9," says Professor Viemann. The PROSPER project (Prevention of Sepsis by personalised nutritional S100A8/A9 supplementation

clinics and health care systems. This is now to change. An international panel of experts led by Professor Dr. Dr. Mike P. Wattjes from the Institute for Diagnostic and Interventional Neuroradiology at the [...] nally standardised for the first time, are a milestone in the care of MS patients," emphasises Professor Wattjes. "Not only do they include all aspects of MS imaging, we also comment in detail on very [...] clinical practice However, the guidelines also mean an enormous relief for the treating physicians, Professor Wattjes notes. They receive a specific application guideline for different patient groups and different

(MHH), in collaboration with specialists from the Neuro-oncology Centre led by Professor Hartmann from Neuropathology and Professor Krauss from Neurosurgery, as well as with partners from the University Medical [...] trait combination of Siglec-16 and polysialic acid, we observed a tumour-inhibiting effect," says Professor Dr Herbert Hildebrandt, project leader in the DFG-funded research group 2953 "Sialic acid as a regulator [...] be detected in more than 80 per cent of the glioblastomas examined," adds Dr Hauke Thiesler from Professor Hildebrandt's research group. "A simple genetic test in combination with other factors could enable

ideal for punctures, for example to take tissue samples or to remove pus accumulations," explains Professor Dr. Frank Wacker, Director of the Institute for Diagnostic and Interventional Radiology. With the [...] punctures are now also easier to perform. The path is determined by the laser beams," explains Professor Wacker. In his institute, the new device is also used for thermal ablations - tumours of the liver [...] we need less time for the interventions and the patients are exposed to less radiation," says Professor Dr. Wacker. In addition, the new device is very suitable for the further training of junior staff

were able to show that we can handle such a pandemic situation excellently," emphasised President Professor Dr Michael Manns on Friday (15 July 2022) during the balance sheet press conference. "We have mastered [...] have always been vigilant. Our doctors and nurses have treated the most seriously ill patients," Professor Manns explained. "Our researchers have been active in and co-founded numerous networks on SARS- [...] clinics, which is about ten per cent less than before the pandemic," emphasised Vice-President Professor Dr Frank Lammert, responsible for patient care at MHH. "Outpatient case numbers and surgery figures

Toxicology at Fraunhofer ITEM (Professor Dr. Armin Braun). After one year, the team can apply for a second round of funding. For further information , please contact Professor Dr. Dr. Axel Schambach, schambach [...] "iGUARD (integrated Guided Ultrafast Antiviral RNAi Drug development)", a research team led by Professor Dr. Dr. Axel Schambach, head of the Institute for Experimental Haematology at the Hannover Medical [...] "RNAi technology uses molecular methods to target the Achilles' heel of viruses, so to speak," says Professor Schambach. To find suitable RNAi candidates, the research team uses artificial intelligence. The

largely unknown. An international research collaboration between Professor Christian Peter Kratz, Hannover Medical School (MHH), Germany, Professor Pierre Hainaut, Institute for Advanced Biosciences, Grenoble [...] SERVICE: For further information , please contact Professor Dr. Christian Kratz, telephone + 49 (511) 532-6712, kratz.christian@mh-hannover.de , or Professor Dr. Pierre Hainaut, telephone + 33 (0)6 20 38 05 [...] can facilitate the search for factors that influence disease severity in people with LFS," says Professor Kratz, Director of the Department of Paediatric Haematology and Oncology of MHH. 3,034 patients

programme is being conducted under the direction of Professor Dr. Jens Vogel-Claussen (Hannover Medical School), Dr. Sabine Bohnet (UKSH Campus Lübeck) and Professor Dr. Martin Reck (LungenClinic Großhansdorf) [...] Radiology and the Department of Pneumology are involved. The head of the study is the radiologist Professor Vogel-Claussen, and senior physician Dr Benjamin-Alexander Bollmann from the Department of Pneumology [...] in Germany within the structures of the German healthcare system for high-risk patients," says Professor Dr Jens Vogel-Claussen, scientific director of the study and principal investigator at MHH. In all